You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leronlimab

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

Solid Tumor, Adult Trial in San Francisco (Leronlimab)

Active, not recruiting
  • Solid Tumor, Adult
  • Leronlimab
  • San Francisco, California
    Quest Clinical Research
Jun 30, 2022

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))

Completed
Has Results
  • Coronavirus Disease 2019
  • Placebo
  • Leronlimab (700mg)
  • Los Angeles, California
  • +11 more
Dec 8, 2022

Metastatic Triple-Negative Breast Carcinoma Trial (Leronlimab)

No longer available
  • Metastatic Triple-Negative Breast Carcinoma
  • Leronlimab
  • (no location specified)
Jan 13, 2022

COVID-19 Pneumonia Trial in Brazil (Leronlimab, Placebo)

Suspended
  • COVID-19 Pneumonia
  • Leronlimab
  • Placebo
  • Ipiaú, BA, Brazil
  • +22 more
Apr 8, 2022

COVID-19 Pneumonia Trial in Brazil (Leronlimab, Placebo)

Suspended
  • COVID-19 Pneumonia
  • Leronlimab
  • Placebo
  • Ipiaú, BA, Brazil
  • +26 more
Apr 8, 2022

Coronavirus Disease 2019 Trial in Aventura, Gainesville (Placebos, Leronlimab (700mg))

Completed
  • Coronavirus Disease 2019
  • Placebos
  • Leronlimab (700mg)
  • Aventura, Florida
  • +1 more
Jul 30, 2021

Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))

Active, not recruiting
  • Coronavirus Disease 2019
  • Placebos
  • Leronlimab (700mg)
  • Alexander City, Alabama
  • +17 more
Jan 13, 2022

HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))

Active, not recruiting
  • HIV
  • PRO 140 (350 mg)
  • +2 more
  • La Mesa, California
  • +11 more
Jan 13, 2022

HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)

Active, not recruiting
  • HIV-1-infection
  • PRO 140 350
  • +2 more
  • San Francisco, California
    Quest Clinical Research
Mar 4, 2022

Hiv, Human Immunodeficiency Virus Trial (PRO 140 SC injections)

Active, not recruiting
  • Hiv
  • Human Immunodeficiency Virus
  • PRO 140 SC injections
  • (no location specified)
Sep 28, 2021

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Active, not recruiting
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    CD01-Extension Investigational Site
Sep 28, 2021

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Completed
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    Quest Clinical Research
Sep 28, 2021

Graft Vs Host Disease Trial in United States (PRO 140)

Terminated
  • Graft Vs Host Disease
  • PRO 140
  • Miami, Florida
  • +7 more
Jan 13, 2022

HIV Trial in Puerto Rico, United States (PRO 140, Placebo, Optimized Background Regimen)

Completed
  • HIV
  • PRO 140
  • +2 more
  • Fountain Valley, California
  • +36 more
Sep 28, 2021

HIV Trial in Orlando (PRO 140)

No longer available
  • HIV
  • PRO 140
  • Orlando, Florida
    CD02 EA Investigational site
Mar 12, 2018

HIV Trial in Phildadelphia (PRO 140)

Withdrawn
  • HIV
  • PRO 140
  • Phildadelphia, Pennsylvania
    Drexel University
Mar 1, 2017

HIV Trial in Philadelphia (PRO 140, Placebo)

Withdrawn
  • HIV
  • PRO 140
  • Placebo
  • Philadelphia, Pennsylvania
    Drexel University College of Medicine
Jan 31, 2017

HIV Trial in United States (PRO 140)

Withdrawn
  • HIV
  • PRO 140
  • Stanford, California
  • +6 more
Mar 7, 2017

HIV Trial in Tarrytown (PRO 140, Placebo)

Completed
Has Results
  • HIV Infections
  • PRO 140
  • Placebo
  • Tarrytown, New York
    Progenics Pharmaceuticals, Inc
Jun 16, 2016

HIV Trial in Lincoln (PRO 140)

Completed
  • HIV Infections
  • PRO 140
  • Lincoln, Nebraska
    MDS Pharma Services
Dec 14, 2015

HIV -1 Infection, HIV Trial in Tarrytown (PRO 140 (humanized mAb to CCR5), Placebo Comparator)

Completed
Has Results
  • HIV -1 Infection
  • HIV Infections
  • PRO 140 (humanized monoclonal antibody to CCR5)
  • Placebo Comparator
  • Tarrytown, New York
    Progenics Pharmaceuticals, Inc.
Dec 14, 2015